Abstract
Introduction
Left ventricular non-compaction (LVNC) is a myocardial disorder characterized by prominent ventricular trabeculations and deep recesses extending from the left ventricular cavity to the sub-endocardial surface of the left ventricular wall with or without left ventricular dysfunction [1] [2] . LVNC can be diagnosed in all stages of life. It has been identi ied as a distinct entity over the past few decades [3] [4] . When the disease is irst recognized, which usually occurs in later stages of life, it is often not clear whether the diagnosis represents late recognition of long-standing non-compaction or delayed morphological manifestation of an underlying cardiomyopathy. LVCN may be associated with other diseases such as neuromuscular disorders 2 . Although the American Heart Association has classi ied LVNC as a primary genetic cardiomyopathy 5 , the European Society of Cardiology refers to LVNC as an 'unclassi ied cardiomyopathy' 6 based on the fact that LVNC is a morphological manifestation of several distinct cardiomyopathies. Currently, there is no de inite evidence to conirm whether LVNC is a distinct cardiomyopathy, an epiphenomenon or a phenotypic variant of other cardiomyopathies. However, the absence of speci ic genotype-phenotype association, the occurrence of LVNC morphology in various metabolic diseases and other cardiomyopathies, and the inding that the LVNC phenotype is not necessary for the development of cardiomyopathy, all suggest it is unlikely that it could be a speci ic cardiomyopathy [7] [8] [9] . Traditionally, diagnosis of LVNC is based on 2D trans-thoracic echocardiography 3 . Although there are three different diagnostic criteria, there is no universally accepted de inition of LVNC. All criteria are based on morphological indings and require the presence of prominent trabeculations with deep intertrabecular recesses communicating with the ventricular cavity and a two-layered appearance of the myocardium (trabecular myocardium as one layer, and compacted myocardium as the second layer) [10] [11] [12] . If a ratio of trabeculated to compact myocardium of more than 2.3 is common in a large-population-based cohort, a critical re-evaluation of the current cardiac magnetic resonance (CMR) criteria for LVNC may be needed 13 . This article discusses the different clinical scenarios of LVNC.
Case report
The irst case concerns a 50-yearold female who came to our medical centre. Subject complained of dyspnea and palpitation on effort for several months, which was attributed to her obesity and lack of exercise. The electrocardiography (ECG) showed a sinus rhythm interrupted by frequent ventricular premature beats, aspeci ic interventricular conduction delay (QRS 140 ms) with a left heart axis. Two dimensional trans-thoracic echocardiography performed with MyLab 30 Gold (ESAOTE Instruments) showed a marked dilatation of the left ventricle with global hypokinesis and very poor systolic function (EF 20%), complicated by severe functional mitral regurgitation by tethering and apical displacement of mitral lea lets; also, a moderate left atrial dilatation and mild tricuspid regurgitation was present without an increase in the systolic pulmonary pressure. Prominent trabeculation was evident on the anterolateral wall, with deep intertrabecular recesses communicating with the ventricular cavity, and a two-layered appearance of the myocardium (trabecular myocardium as one layer, and compacted myocardium as the second layer; see Figure 1 ). In addition, intertrabecular space was illed by direct blood low from the ventricular cavity as visualized on colour Doppler imaging. The diagnosis of non-ischemic dilated cardiomyopathy in LVNC was made and subsequently a cardiac magnetic resonance con irmed this disease (see Figure 2) .
The Instruments) . This exam showed a non-dilated left ventricle with good systolic function (estimated EF 65%) and absence of valvular disease or other abnormalities, but the presence of a myocardial disorder characterized by prominent ventricular trabeculations and deep recesses extending from the left ventricular cavity to the sub-endocardial surface of the whole anterolateral left ventricular wall (see Figure 3) . Mild right ventricular involvement was also shown (see red arrow). Subsequently, a CMR showed the typical morphologic indings of left ventricular non-compaction of the anterolateral wall (see Figure 4 ) without dysfunction.
The third case concerns the incidental inding of non-compacted myocardium in a 48-year-old female cyclist who was asymptomatic. This athlete was subjected to sports screening prior to participation. Subject had no family history of cardiac disease or sudden death. Physical examination revealed the presence of a slight heart murmur. Resting ECG showed normal sinus rhythm, and exercise testing was negative for arrhythmias. Echocardiography examination showed periapical and apical thickening with spongiform appearance of the myocardium and deep intertrabecular recesses with the association of a false tendon inside the cavity (see Figures 5 and 6 ). The diagnosis of LVNC myocardium was made. In this case, the athlete has refused to undergo MRI.
Discussion
These three case reports describe different clinical scenarios of the same pathology and then three totally opposite sides of the same structural morphological abnormality of the myocardium. In the irst case, the LVNC is related to an important base of cardiomyopathy such as dilated cardiomyopathy, which causes a severe dysfunction of the left ventricle and requires suitable treatments and therapies; in the second case, the same morphological alteration of the myocardium in a subject appears perfectly healthy and suitable to the athletic skills of that subject, who is completely asymptomatic. It follows that prominent left ventricular trabeculation can be found in asymptomatic, healthy athletes as well as in subjects with hypertrophic or dilated cardiomyopathy 14 . Thus, the difference between variants and LVNC may often be challenging. What makes the difference, in our opinion, is not the morphology but the function of the myocardium affected and the absence of other associated anomalies that determine the prognosis of these patients.
Conclusion
The variety in clinical presentation, genetic heterogeneity and phenotype of the irst transgenic animal model of an LVNC-associated mutation question the hypothesis that LVNC be a distinct cardiomyopathy. It seems to be a distinct phenotype or phenotypic, morphological expression of different underlying diseases rather than a distinct cardiomyopathy. We believe that any person can have non-compaction myocardium and that this development is not only about the genetic basis but also about physiological basis, such as exercise, and that this does not exclude sporting activities in which these subjects participate.
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